On the public citation graph

Mutations in DNA damage response pathways as a potential biomarker for immune checkpoint blockade efficacy: evidence from a seven-cancer immunotherapy cohort

0 signed · 67 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jamaoncol.2018.2805openalex-snapshot
Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer
inferredcites →https://doi.org/10.1001/jamaoncol.2018.7098openalex-snapshot
Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel
inferredcites →https://doi.org/10.1001/jamaoncol.2019.2963openalex-snapshot
Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types
inferredcites →https://doi.org/10.1001/jamaoncol.2019.3158openalex-snapshot
Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma
inferredcites →https://doi.org/10.1016/j.ccell.2018.03.015openalex-snapshot
The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy
inferredcites →https://doi.org/10.1016/j.ccell.2018.04.001openalex-snapshot
Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1016/j.cell.2014.12.033openalex-snapshot
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
inferredcites →https://doi.org/10.1016/j.cell.2015.05.044openalex-snapshot
Genomic Classification of Cutaneous Melanoma
inferredcites →https://doi.org/10.1016/j.cell.2016.02.065openalex-snapshot
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
inferredcites →https://doi.org/10.1016/j.jtho.2020.05.019openalex-snapshot
The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
inferredcites →https://doi.org/10.1016/s0140-6736(15)01281-7openalex-snapshot
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
inferredcites →https://doi.org/10.1016/s1470-2045(16)30406-5openalex-snapshot
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
inferredcites →https://doi.org/10.1038/nature03482openalex-snapshot
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
inferredcites →https://doi.org/10.1038/ncomms15180openalex-snapshot
A molecular portrait of microsatellite instability across multiple cancers
inferredcites →https://doi.org/10.1038/ncomms3612openalex-snapshot
Inferring tumour purity and stromal and immune cell admixture from expression data
inferredcites →https://doi.org/10.1038/ni.3290openalex-snapshot
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
inferredcites →https://doi.org/10.1038/nmeth.3337openalex-snapshot
Robust enumeration of cell subsets from tissue expression profiles
inferredcites →https://doi.org/10.1038/nrc.2015.2openalex-snapshot
DNA damage and the balance between survival and death in cancer biology
inferredcites →https://doi.org/10.1038/nrc.2015.4openalex-snapshot
DNA repair, genome stability and cancer: a historical perspective
inferredcites →https://doi.org/10.1038/nri.2016.90openalex-snapshot
Sex differences in immune responses
inferredcites →https://doi.org/10.1038/s41467-020-15679-xopenalex-snapshot
Sex-associated molecular differences for cancer immunotherapy
inferredcites →https://doi.org/10.1038/s41467-020-17981-0openalex-snapshot
Strength of immune selection in tumors varies with sex and age
inferredcites →https://doi.org/10.1038/s41588-018-0312-8openalex-snapshot
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
inferredcites →https://doi.org/10.1056/nejmoa1504030openalex-snapshot
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
inferredcites →https://doi.org/10.1056/nejmoa1606774openalex-snapshot
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmoa1613493openalex-snapshot
First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1056/nejmp1709968openalex-snapshot
First FDA Approval Agnostic of Cancer Site — When a Biomarker Defines the Indication
inferredcites →https://doi.org/10.1056/nejmra0804615openalex-snapshot
DNA Damage, Aging, and Cancer
inferredcites →https://doi.org/10.1093/annonc/mdy470openalex-snapshot
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy
inferredcites →https://doi.org/10.1093/bioinformatics/btw325openalex-snapshot
GenVisR: Genomic Visualizations in R
inferredcites →https://doi.org/10.1098/rspb.2014.3085openalex-snapshot
Evolution of the immune system in humans from infancy to old age
inferredcites →https://doi.org/10.1126/science.aaa1348openalex-snapshot
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
inferredcites →https://doi.org/10.1126/science.aad0095openalex-snapshot
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
inferredcites →https://doi.org/10.1146/annurev-pathol-012615-044446openalex-snapshot
Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies
inferredcites →https://doi.org/10.1158/0008-5472.can-18-1814openalex-snapshot
Comutations in DNA Damage Response Pathways Serve as Potential Biomarkers for Immune Checkpoint Blockade
inferredcites →https://doi.org/10.1158/2159-8290.cd-17-0226openalex-snapshot
DNA Damage and Repair Biomarkers of Immunotherapy Response
inferredcites →https://doi.org/10.1159/000453569openalex-snapshot
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
inferredcites →https://doi.org/10.1159/000455014openalex-snapshot
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
inferredcites →https://doi.org/10.1172/jci.insight.127901openalex-snapshot
Titin mutation associated with responsiveness to checkpoint blockades in solid tumors
inferredcites →https://doi.org/10.1172/jci84940openalex-snapshot
Immune activation and response to pembrolizumab in POLE-mutant endometrial cancer
inferredcites →https://doi.org/10.1172/jci91190openalex-snapshot
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
inferredcites →https://doi.org/10.1186/1471-2105-14-7openalex-snapshot
GSVA: gene set variation analysis for microarray and RNA-Seq data
inferredcites →https://doi.org/10.1186/gb-2013-14-4-r34openalex-snapshot
Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis
inferredcites →https://doi.org/10.1186/s13059-014-0550-8openalex-snapshot
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
inferredcites →https://doi.org/10.1200/jco.2017.75.7740openalex-snapshot
Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1/PD-L1 Blockade in Advanced Urothelial Cancers
inferredcites →https://doi.org/10.18632/aging.103296openalex-snapshot
High mutation load, immune-activated microenvironment, favorable outcome, and better immunotherapeutic efficacy in melanoma patients harboring MUC16/CA125 mutations
inferredcites →https://doi.org/10.3389/fgene.2020.00933openalex-snapshot
ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4820044openalex-extracted
The Mutational Landscape of Homologous Recombination Repair (Hrr) Genes and Their Impacts on Metastatic Colorectal Cancer Patients Treated With Immunotherapy
inferred← citeshttps://doi.org/10.1016/j.bbcan.2023.188910openalex-snapshot
Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2025.105043openalex-snapshot
MSH2 in colorectal cancer: A comprehensive review of molecular mechanisms, clinical prognosis, and a precision oncology framework
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e13661openalex-snapshot
Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature
inferred← citeshttps://doi.org/10.1016/j.wneu.2023.05.107openalex-snapshot
Identification of DNA Damage Repair Gene Signature as a Novel Prognostic Marker in Glioblastoma Multiforme
inferred← citeshttps://doi.org/10.1038/s41419-024-06911-3openalex-snapshot
ATM inhibition enhance immunotherapy by activating STING signaling and augmenting MHC Class I
inferred← citeshttps://doi.org/10.1080/1750743x.2025.2590474openalex-snapshot
Ataxia Telangiectasia Mutated (ATM) gene alterations as biomarkers of response to immune checkpoint inhibitors
inferred← citeshttps://doi.org/10.1186/s12967-026-07680-7openalex-snapshot
MTHFD2 is required for DNA repair and implicated in LUAD radiotherapy resistance
inferred← citeshttps://doi.org/10.1186/s40001-024-01678-xopenalex-snapshot
DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications
inferred← citeshttps://doi.org/10.1200/po.23.00279openalex-snapshot
Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study
inferred← citeshttps://doi.org/10.1590/1678-4685-gmb-2024-0138openalex-snapshot
DNA damage repair-related methylated genes RRM2 and GAPDH are prognostic biomarkers associated with immunotherapy for lung adenocarcinoma
inferred← citeshttps://doi.org/10.3389/fimmu.2021.784336openalex-snapshot
Good Tumor Response to Chemoradioimmunotherapy in dMMR/MSI-H Advanced Colorectal Cancer: A Case Series
inferred← citeshttps://doi.org/10.3390/cells12091288openalex-snapshot
ATM Inhibition-Induced ISG15/IFI27/OASL Is Correlated with Immunotherapy Response and Inflamed Immunophenotype
inferred← citeshttps://doi.org/10.6084/m9.figshare.25183293openalex-snapshot
Additional file 1 of DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications
inferred← citeshttps://doi.org/10.6084/m9.figshare.25183382openalex-snapshot
Additional file 2 of DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications
inferred← citeshttps://doi.org/10.6084/m9.figshare.26678057openalex-snapshot
Additional file 3 of DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications
inferred← citeshttps://doi.org/10.6084/m9.figshare.26678060openalex-snapshot
Additional file 4 of DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications
inferred← citeshttps://doi.org/10.6084/m9.figshare.26678063openalex-snapshot
Additional file 5 of DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications
inferred← citeshttps://doi.org/10.6084/m9.figshare.26678066openalex-snapshot
Additional file 6 of DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications
inferred← citeshttps://doi.org/10.6084/m9.figshare.26678069openalex-snapshot
Additional file 7 of DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.